[1]Phinney DG. Building a consensus regarding the nature and origin of mesenchymal stem cells. J Cell Biochem Suppl. 2002;38:7-12.[2]Pittenger MF, Mackay AM, Beck SC,et al. Multilineage potential of adult human mesenchymal stem cells.Science. 1999;284(5411):143-147.[3]Campagnoli C, Roberts IA, Kumar S,et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow.Blood. 2001;98(8):2396-2402.[4]in 't Anker PS, Noort WA, Scherjon SA,et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica. 2003;88(8):845-852.[5]Zuk PA, Zhu M, Mizuno H,et al.Multilineage cells from human adipose tissue: implications for cell-based therapies.Tissue Eng. 2001;7(2):211-228.[6]Zuk PA, Zhu M, Ashjian P,et al.Human adipose tissue is a source of multipotent stem cells.Mol Biol Cell. 2002;13(12): 4279-4295.[7]Kuznetsov SA, Mankani MH, Gronthos S,et al. Circulating skeletal stem cells.J Cell Biol. 2001;153(5):1133-1140.[8]Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp.J Bone Miner Res. 2003;18(4):696-704.[9]Gronthos S, Mankani M, Brahim J,et al. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo.Proc Natl Acad Sci U S A. 2000;97(25):13625-13630.[10]Pierdomenico L, Bonsi L, Calvitti M,et al. Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp.Transplantation. 2005;80(6): 836-842.[11]Igura K, Zhang X, Takahashi K,et al.Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta.Cytotherapy. 2004;6(6): 543-553.[12]Fukuchi Y, Nakajima H, Sugiyama D,et al.Human placenta-derived cells have mesenchymal stem/progenitor cell potential.Stem Cells. 2004;22(5):649-658.[13]You Q, Cai L, Zheng J,et al.Isolation of human mesenchymal stem cells from third-trimester amniotic fluid.Int J Gynaecol Obstet. 2008;103(2):149-152.[14]Tsai MS, Lee JL, Chang YJ,et al.Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol.Hum Reprod. 2004;19(6):1450-1456.[15]Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood.Br J Haematol. 2000; 109(1):235-242.[16]Romanov YA, Svintsitskaya VA, Smirnov VN.Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord.Stem Cells. 2003;21(1):105-110.[17]Wang HS, Hung SC, Peng ST,et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells. 2004;22(7):1330-1337.[18]Weiss ML, Medicetty S, Bledsoe AR, et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells. 2006;24(3):781-792.[19]Sarugaser R, Lickorish D, Baksh D,et al.Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors.Stem Cells. 2005;23(2):220-229.[20]Hu Y, Liao L, Wang Q,et al.Isolation and identification of mesenchymal stem cells from human fetal pancreas.J Lab Clin Med. 2003;141(5):342-349.[21]da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119(Pt 11):2204-2213. [22]Horwitz EM, Le Blanc K, Dominici M,et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.Cytotherapy. 2005;7(5):393-395.[23]Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.[24]Campagnoli C, Roberts IA, Kumar S,et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001;98(8): 2396-2402.[25]Götherström C, Ringdén O, Westgren M,et al. Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells.Bone Marrow Transplant. 2003; 32(3):265-272.[26]Götherström C, West A, Liden J, et al. Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells. Haematologica. 2005;90(8): 1017-1026.[27]Guillot PV, Gotherstrom C, Chan J, et al. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC.Stem Cells. 2007;25(3):646-654.[28]Carlin R, Davis D, Weiss M, et al. Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells.Reprod Biol Endocrinol. 2006;4:8.[29]Friedman R, Betancur M, Boissel L, et al. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation.Biol Blood Marrow Transplant. 2007; 13(12): 1477-1486.[30]Troyer DL, Weiss ML.Wharton's jelly-derived cells are a primitive stromal cell population.Stem Cells. 2008;26(3): 591-599.[31]Weiss ML, Medicetty S, Bledsoe AR, et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells. 2006;24(3):781-792.[32]Wang XY, Lan Y, He WY, et al. Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos. Blood. 2008;111(4):2436-2443.[33]Fong CY, Richards M, Manasi N, et al. Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. Reprod Biomed Online. 2007;15(6):708- 718.[34]Can A, Karahuseyinoglu S. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells. 2007;25(11):2886-2895.[35]La Rocca G, Anzalone R, Corrao S,et al. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol. 2009; 131(2): 267-282.[36]Fong CY, Chak LL, Biswas A, et al. Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev. 2011;7(1):1-16.[37]Salehinejad P, Alitheen NB, Ali AM,et al. Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly. In Vitro Cell Dev Biol Anim. 2012;48(2):75-83.[38]De Bruyn C, Najar M, Raicevic G, et al. A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem Cells Dev. 2011;20(3):547-557.[39]Nekanti U, Rao VB, Bahirvani AG, et al. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells. Stem Cells Dev. 2010; 19(1):117-130.[40]Nekanti U, Mohanty L, Venugopal P,et al. Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications. Stem Cell Res. 2010;5(3):244-254.[41]Nekanti U, Dastidar S, Venugopal P,et al. Increased proliferation and analysis of differential gene expression in human Wharton's jelly-derived mesenchymal stromal cells under hypoxia. Int J Biol Sci. 2010;6(5):499-512.[42]周建,葛宝丰,王家琪,等.不同处理时间50 Hz3.6 mT的正弦交变磁场对人脐带干细胞增殖与成骨性分化的研究[J]. 重庆医科大学学报,2012,37(1):51-55.[43]朱少芳,何援利,付霞霏.人脐带间充质干细胞的生物学特性和超微结构[J].中国医学科学院学报,2011,33(4):382-386.[44]陈丽,吴本清,朱华民.原子力显微镜观察人脐带间充质干细胞:生物学特性与超微结构的关系[J].中国组织工程研究与临床康复, 2010,14(6):996-1001.[45]Garzón I, Pérez-Köhler B, Garrido-Gómez J, et al. Evaluation of the cell viability of human Wharton's jelly stem cells for use in cell therapy.Tissue Eng Part C Methods. 2012;18(6): 408-419.[46]Kim MJ, Shin KS, Jeon JH, et al. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.Cell Tissue Res. 2011;346(1):53-64.[47]Nekanti U, Rao VB, Bahirvani AG,et al. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells.Stem Cells Dev. 2010; 19(1):117-130.[48]Balasubramanian S, Venugopal P, Sundarraj S, et al. Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells.Cytotherapy. 2012;14(1):26-33.[49]Hsieh JY, Fu YS, Chang SJ,et al. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord. Stem Cells Dev. 2010;19(12): 1895-1910.[50]Angelucci S, Marchisio M, Di Giuseppe F, et al. Proteome analysis of human Wharton's jelly cells during in vitro expansion. Proteome Sci. 2010;8:18.[51]Chen H, Zhang N, Li T,et al. Human umbilical cord Wharton's jelly stem cells: immune property genes assay and effect of transplantation on the immune cells of heart failure patients. Cell Immunol. 2012;276(1-2):83-90.[52]Zhou C, Yang B, Tian Y,et al. Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes. Cell Immunol. 2011;272(1): 33-38.[53]Valencic E, Piscianz E, Andolina M,et al. The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation. Cytotherapy. 2010;12(2):154-160.[54]Najar M, Raicevic G, Boufker HI, et al. Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources.Cell Immunol. 2010; 264(2):171-179.[55]Najar M, Raicevic G, Boufker HI, et al. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. Tissue Eng Part A. 2010;16(11):3537-3546.[56]Fong CY, Chak LL, Biswas A, et al. Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev. 2011;7(1):1-16.[57]Gauthaman K, Fong CY, Suganya CA, et al. Extra-embryonic human Wharton's jelly stem cells do not induce tumorigenesis, unlike human embryonic stem cells. Reprod Biomed Online. 2012;24(2):235-246.[58]阮忠宝,杨向军,陈各才,等.5-氮杂胞苷诱导人脐带间充质干细胞向心肌样细胞的分化[J].中国组织工程研究与临床康复,2011, 15(36):6705-6708.[59]唐欣,王岩,易海波,等.不同浓度5-氮胞苷体外诱导人脐带间充质干细胞向心肌样细胞的分化[J].中国组织工程研究与临床康复, 2011,15(40):7459-7462.[60]Pereira WC, Khushnooma I, Madkaikar M,et al. Reproducible methodology for the isolation of mesenchymal stem cells from human umbilical cord and its potential for cardiomyocyte generation.J Tissue Eng Regen Med. 2008;2(7):394-399.[61]Lupu M, Khalil M, Andrei E, et al. Integration properties of Wharton's jelly-derived novel mesenchymal stem cells into ventricular slices of murine hearts.Cell Physiol Biochem. 2011;28(1):63-76.[62]何红燕,林晓波,应文娟.人脐带间充质干细胞经体内定植并向心肌样细胞分化的研究[J].中国输血杂志,2009,22(3):188-191.[63]Wu KH, Mo XM, Zhou B, et al. Cardiac potential of stem cells from whole human umbilical cord tissue.J Cell Biochem. 2009;107(5):926-932.[64]Latifpour M, Nematollahi-Mahani SN, Deilamy M, et al. Improvement in cardiac function following transplantation of human umbilical cord matrix-derived mesenchymal cells. Cardiology. 2011;120(1):9-18.[65]Madonna R, De Caterina R, Willerson JT, et al. Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration. Eur Heart J. 2011;32(10):1190-1196.[66]Vassalli G, Moccetti T. Cardiac repair with allogeneic mesenchymal stem cells after myocardial infarction. Swiss Med Wkly. 2011;141:w13209.[67]Liu L, Chai J, Han Y,et al. Research progress of biological characteristics and advantages of Wharton's jelly-mesenchymal stem cells. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2011;25(6):745-749.[68]Fong CY, Subramanian A, Biswas A, et al. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells. Reprod Biomed Online. 2010;21(3):391-401.[69]Weiss ML, Anderson C, Medicetty S,et al. Immune properties of human umbilical cord Wharton's jelly-derived cells.Stem Cells. 2008;26(11):2865-2874. |